Several neutralizing monoclonal antibodies (mAbs) to severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) have been developed and are now under evaluation in clinical …

Background Globally, increasing coronavirus disease (COVID-19) vaccination coverage
remains a major public health concern in the face of high rates of COVID-19 hesitancy …

Background The outbreak and pandemic of coronavirus SARS-CoV-2 caused significant
threaten to global public health and economic consequences. It is extremely urgent that …

Background Quantitative serological assays detecting response to SARS-CoV-2 are needed
to quantify immunity. This study analyzed the performance and correlation of two quantitative …

Novel therapies for the treatment of COVID-19 are continuing to emerge as the SARS-Cov-2
pandemic progresses. PCR remains the standard benchmark for initial diagnosis of COVID …

The global impact imposed by the coronavirus disease 2019 (COVID-19) pandemic may be
soon alleviated by the introduction and worldwide dissemination of safe and effective …

Background: The COVID-19 pandemic, caused by a novel coronavirus termed SARS-CoV-2,
has spread quickly worldwide. Convalescent plasma (CP) obtained from patients following …

The present pandemic has posed a crisis to the economy of the world and the health sector.
Therefore, the race to expand research to understand some good molecular targets for …

Abstract Background The Coronavirus disease 2019 (COVID‐19) pandemic is having a
major global impact, and the resultant response in the development of new diagnostics is …

The COVID-19 pandemic, which began at the end of 2019 in Wuhan, has affected 220
countries and territories to date. In the present study, we studied humoral immunity in …